Status: Recruiting
Carotid Revascularization With MicroNet Covered Stent Comparing Early Neurological Outcomes With Distal Versus Proximal EPS
The SIBERIA study demonstrated a clear advantage of CGuard stent implantation over the existing classical stent when using a distal anti-embolic device. At the same time, there is no Level 1 evidence for a difference between the proximal and distal anti-embolic device for the CGuard stent.
Participants needed: 366
Trial details
Age: 45-80Biological sex: AllType: InterventionalSponsor: Meshalkin Research Institute of Pathology of CirculationUpdated: Feb 25, 2022Locations: 1
Eligibility criteria
Consecutive patients 45-80 years old accepted for CAS following neurological con... [+4]
Currently enrolled in another investigational device or drug study that has not... [+7]